INTERPARFUMS INC — Financial Data
Annual figures from SEC EDGAR XBRL filings (10-K)
These figures are extracted directly from XBRL-tagged financial statements that INTERPARFUMS INC filed with the SEC as part of its annual 10-K reports. XBRL (eXtensible Business Reporting Language) is a structured data format the SEC requires for machine-readable financial disclosures. Values shown are as reported — negative figures indicate a loss and are shown in red.
Revenue
Total revenue from all business activities — the top line of the income statement. Represents all money earned before any expenses are deducted.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2023 | Dec 31, 2023 | $1.32B | Feb 27, 2024 |
| FY2023 | Dec 31, 2022 | $1.09B | Feb 27, 2024 |
| FY2023 | Dec 31, 2021 | $879.50M | Feb 27, 2024 |
| FY2022 | Dec 31, 2020 | $539.00M | Feb 28, 2023 |
| FY2021 | Dec 31, 2019 | $713.50M | Mar 1, 2022 |
| FY2020 | Dec 31, 2018 | $675.60M | Mar 1, 2021 |
| FY2018 | Dec 31, 2017 | $591.25M | Mar 1, 2019 |
| FY2018 | Dec 31, 2016 | $521.07M | Mar 1, 2019 |
| FY2014 | Dec 31, 2014 | $499.30M | Mar 11, 2015 |
| FY2014 | Dec 31, 2013 | $563.60M | Mar 11, 2015 |
Revenue
Revenue recognized from contracts with customers under ASC 606, excluding taxes collected on behalf of government authorities. This is the primary revenue concept for many companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2020 | Dec 31, 2020 | $71.50M | Mar 1, 2021 |
| FY2020 | Dec 31, 2019 | $112.00M | Mar 1, 2021 |
| FY2020 | Dec 31, 2018 | $95.10M | Mar 1, 2021 |
Revenue (Net Sales)
Net sales revenue — gross revenue less returns, allowances, and discounts. Used by many manufacturers and retailers as the primary top-line figure.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2017 | Dec 31, 2017 | $591.25M | Mar 13, 2018 |
| FY2017 | Dec 31, 2016 | $521.07M | Mar 13, 2018 |
| FY2017 | Dec 31, 2015 | $468.54M | Mar 13, 2018 |
| FY2016 | Dec 31, 2014 | $499.26M | Mar 13, 2017 |
| FY2015 | Dec 31, 2013 | $563.58M | Mar 14, 2016 |
| FY2014 | Dec 31, 2012 | $654.12M | Mar 11, 2015 |
| FY2013 | Dec 31, 2011 | $615.22M | Mar 11, 2014 |
| FY2012 | Dec 31, 2010 | $460.41M | Mar 12, 2013 |
| FY2011 | Dec 31, 2009 | $409.46M | Mar 12, 2012 |
Gross Profit
Revenue minus the cost of goods sold (COGS). Gross profit shows how much revenue remains to cover operating expenses, R&D, and administrative costs before calculating operating income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $947.22M | Mar 10, 2026 |
| FY2025 | Dec 31, 2024 | $927.34M | Mar 10, 2026 |
| FY2025 | Dec 31, 2023 | $839.08M | Mar 10, 2026 |
| FY2024 | Dec 31, 2022 | $694.42M | Mar 11, 2025 |
| FY2023 | Dec 31, 2021 | $556.90M | Feb 27, 2024 |
| FY2022 | Dec 31, 2020 | $330.73M | Feb 28, 2023 |
| FY2021 | Dec 31, 2019 | $445.94M | Mar 1, 2022 |
| FY2020 | Dec 31, 2018 | $427.56M | Mar 1, 2021 |
| FY2019 | Dec 31, 2017 | $376.29M | Mar 2, 2020 |
| FY2018 | Dec 31, 2016 | $326.47M | Mar 1, 2019 |
Net Income
The bottom-line profit — what remains after all operating expenses, interest, taxes, and other costs are deducted. A negative value means the company reported a net loss for the year.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $168.39M | Mar 10, 2026 |
| FY2025 | Dec 31, 2024 | $164.36M | Mar 10, 2026 |
| FY2025 | Dec 31, 2023 | $152.65M | Mar 10, 2026 |
| FY2024 | Dec 31, 2022 | $120.94M | Mar 11, 2025 |
| FY2023 | Dec 31, 2021 | $87.41M | Feb 27, 2024 |
| FY2022 | Dec 31, 2020 | $38.22M | Feb 28, 2023 |
| FY2021 | Dec 31, 2019 | $60.25M | Mar 1, 2022 |
| FY2020 | Dec 31, 2018 | $53.79M | Mar 1, 2021 |
| FY2019 | Dec 31, 2017 | $41.59M | Mar 2, 2020 |
| FY2018 | Dec 31, 2016 | $33.33M | Mar 1, 2019 |
Operating Income
Profit from core business operations before interest expense and income taxes (also known as EBIT). Excludes non-operating items, making it a cleaner measure of operational efficiency than net income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $270.32M | Mar 10, 2026 |
| FY2025 | Dec 31, 2024 | $274.80M | Mar 10, 2026 |
| FY2025 | Dec 31, 2023 | $251.38M | Mar 10, 2026 |
| FY2024 | Dec 31, 2022 | $194.30M | Mar 11, 2025 |
| FY2023 | Dec 31, 2021 | $148.05M | Feb 27, 2024 |
| FY2022 | Dec 31, 2020 | $70.08M | Feb 28, 2023 |
| FY2021 | Dec 31, 2019 | $104.73M | Mar 1, 2022 |
| FY2020 | Dec 31, 2018 | $94.73M | Mar 1, 2021 |
| FY2019 | Dec 31, 2017 | $78.62M | Mar 2, 2020 |
| FY2018 | Dec 31, 2016 | $66.68M | Mar 1, 2019 |
SG&A Expense
Selling, general, and administrative expenses — the overhead costs of running the business, including salaries, marketing, legal fees, and corporate office costs. Excludes COGS and R&D.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $676.90M | Mar 10, 2026 |
| FY2025 | Dec 31, 2024 | $648.54M | Mar 10, 2026 |
| FY2025 | Dec 31, 2023 | $587.70M | Mar 10, 2026 |
| FY2024 | Dec 31, 2022 | $492.37M | Mar 11, 2025 |
| FY2023 | Dec 31, 2021 | $406.46M | Feb 27, 2024 |
| FY2022 | Dec 31, 2020 | $260.65M | Feb 28, 2023 |
| FY2021 | Dec 31, 2019 | $341.21M | Mar 1, 2022 |
| FY2020 | Dec 31, 2018 | $332.83M | Mar 1, 2021 |
| FY2019 | Dec 31, 2017 | $295.54M | Mar 2, 2020 |
| FY2018 | Dec 31, 2016 | $258.79M | Mar 1, 2019 |
Operating Cash Flow
Cash generated from core business operations — a more reliable measure of financial health than net income because it strips out non-cash items like depreciation and one-time charges.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $214.90M | Mar 10, 2026 |
| FY2025 | Dec 31, 2024 | $187.64M | Mar 10, 2026 |
| FY2025 | Dec 31, 2023 | $105.77M | Mar 10, 2026 |
| FY2024 | Dec 31, 2022 | $73.03M | Mar 11, 2025 |
| FY2023 | Dec 31, 2021 | $119.59M | Feb 27, 2024 |
| FY2022 | Dec 31, 2020 | $64.99M | Feb 28, 2023 |
| FY2021 | Dec 31, 2019 | $76.45M | Mar 1, 2022 |
| FY2020 | Dec 31, 2018 | $63.04M | Mar 1, 2021 |
| FY2019 | Dec 31, 2017 | $35.89M | Mar 2, 2020 |
| FY2018 | Dec 31, 2016 | $54.56M | Mar 1, 2019 |
Capital Expenditures (Capex)
Cash spent on acquiring or upgrading physical assets — property, equipment, and infrastructure. High capex businesses include manufacturing, telecom, and energy companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $24.41M | Mar 10, 2026 |
| FY2025 | Dec 31, 2024 | $4.74M | Mar 10, 2026 |
| FY2025 | Dec 31, 2023 | $6.47M | Mar 10, 2026 |
| FY2024 | Dec 31, 2022 | $33.76M | Mar 11, 2025 |
| FY2023 | Dec 31, 2021 | $141.27M | Feb 27, 2024 |
| FY2022 | Dec 31, 2020 | $11.01M | Feb 28, 2023 |
| FY2020 | Dec 31, 2019 | $5.43M | Mar 1, 2021 |
| FY2020 | Dec 31, 2018 | $3.96M | Mar 1, 2021 |
| FY2019 | Dec 31, 2017 | $3.02M | Mar 2, 2020 |
| FY2018 | Dec 31, 2016 | $4.78M | Mar 1, 2019 |
Total Assets
The total value of everything the company owns or controls — cash, investments, receivables, property, equipment, and intangibles. Reported as of fiscal year end.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $1.59B | Mar 10, 2026 |
| FY2025 | Dec 31, 2024 | $1.41B | Mar 10, 2026 |
| FY2025 | Dec 31, 2023 | $1.37B | Mar 10, 2026 |
| FY2024 | Dec 31, 2022 | $1.31B | Mar 11, 2025 |
| FY2023 | Dec 31, 2021 | $1.15B | Feb 27, 2024 |
| FY2022 | Dec 31, 2020 | $890.15M | Feb 28, 2023 |
| FY2021 | Dec 31, 2019 | $828.83M | Mar 1, 2022 |
| FY2020 | Dec 31, 2018 | $797.83M | Mar 1, 2021 |
| FY2019 | Dec 31, 2017 | $777.77M | Mar 2, 2020 |
| FY2018 | Dec 31, 2016 | $682.41M | Mar 1, 2019 |
Stockholders Equity
The net worth attributable to shareholders: total assets minus total liabilities. Also called book value. Can be negative if liabilities exceed assets, which is common in capital-intensive industries.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $880.72M | Mar 10, 2026 |
| FY2025 | Dec 31, 2024 | $744.87M | Mar 10, 2026 |
| FY2024 | Dec 31, 2023 | $699.39M | Mar 11, 2025 |
| FY2023 | Dec 31, 2022 | $616.78M | Feb 27, 2024 |
| FY2022 | Dec 31, 2021 | $571.92M | Feb 28, 2023 |
| FY2021 | Dec 31, 2020 | $535.84M | Mar 1, 2022 |
| FY2020 | Dec 31, 2019 | $468.00M | Mar 1, 2021 |
| FY2019 | Dec 31, 2018 | $447.61M | Mar 2, 2020 |
| FY2018 | Dec 31, 2017 | $433.30M | Mar 1, 2019 |
| FY2017 | Dec 31, 2016 | $370.39M | Mar 13, 2018 |
Goodwill
An intangible asset representing the premium paid above fair value when acquiring another company. A large goodwill balance signals a history of acquisitions at premium prices.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2012 | Dec 31, 2012 | $954.0K | Mar 12, 2013 |
| FY2011 | Dec 31, 2011 | $2.76M | Mar 12, 2012 |
| FY2011 | Dec 31, 2010 | $3.65M | Mar 12, 2012 |
Retained Earnings
Cumulative net income kept by the company rather than distributed as dividends. A growing retained earnings balance indicates consistent profitability; a deficit indicates cumulative losses.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $828.91M | Mar 10, 2026 |
| FY2025 | Dec 31, 2024 | $763.24M | Mar 10, 2026 |
| FY2024 | Dec 31, 2023 | $693.85M | Mar 11, 2025 |
| FY2023 | Dec 31, 2022 | $620.10M | Feb 27, 2024 |
| FY2022 | Dec 31, 2021 | $560.66M | Feb 28, 2023 |
| FY2021 | Dec 31, 2020 | $503.57M | Mar 1, 2022 |
| FY2020 | Dec 31, 2019 | $474.64M | Mar 1, 2021 |
| FY2019 | Dec 31, 2018 | $448.73M | Mar 2, 2020 |
| FY2018 | Dec 31, 2017 | $422.57M | Mar 1, 2019 |
| FY2017 | Dec 31, 2016 | $402.71M | Mar 13, 2018 |
Cash & Equivalents
Highly liquid assets the company holds — cash on hand, bank balances, and short-term investments with maturities of three months or less. A key indicator of short-term financial health.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2023 | Dec 31, 2021 | $159.61B | Feb 27, 2024 |
| FY2021 | Dec 31, 2020 | $169.68M | Mar 1, 2022 |
| FY2021 | Dec 31, 2019 | $133.42M | Mar 1, 2022 |
| FY2021 | Dec 31, 2018 | $193.14M | Mar 1, 2022 |
| FY2020 | Dec 31, 2017 | $208.34M | Mar 1, 2021 |
| FY2019 | Dec 31, 2016 | $161.83M | Mar 2, 2020 |
| FY2018 | Dec 31, 2015 | $176.97M | Mar 1, 2019 |
| FY2017 | Dec 31, 2014 | $90.14M | Mar 13, 2018 |
| FY2016 | Dec 31, 2013 | $125.65M | Mar 13, 2017 |
| FY2015 | Dec 31, 2012 | $307.34M | Mar 14, 2016 |
Long-Term Debt
Debt obligations due more than one year from the balance sheet date — bonds, term loans, and notes payable. High long-term debt relative to equity can signal elevated financial leverage.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $176.03M | Mar 10, 2026 |
| FY2025 | Dec 31, 2024 | $157.34M | Mar 10, 2026 |
| FY2024 | Dec 31, 2023 | $157.48M | Mar 11, 2025 |
| FY2023 | Dec 31, 2022 | $180.04M | Feb 27, 2024 |
| FY2022 | Dec 31, 2021 | $148.80M | Feb 28, 2023 |
| FY2021 | Dec 31, 2020 | $24.71M | Mar 1, 2022 |
| FY2020 | Dec 31, 2019 | $23.06M | Mar 1, 2021 |
| FY2019 | Dec 31, 2018 | $46.06M | Mar 2, 2020 |
| FY2018 | Dec 31, 2017 | $60.58M | Mar 1, 2019 |
EPS (Basic)
Net income divided by the weighted average shares outstanding. Basic EPS does not account for dilutive securities like options or convertible bonds — use diluted EPS for a more conservative view.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 5 | Mar 10, 2026 |
| FY2025 | Dec 31, 2024 | 5 | Mar 10, 2026 |
| FY2025 | Dec 31, 2023 | 4 | Mar 10, 2026 |
| FY2024 | Dec 31, 2022 | 3 | Mar 11, 2025 |
| FY2023 | Dec 31, 2021 | 2 | Feb 27, 2024 |
| FY2022 | Dec 31, 2020 | 1 | Feb 28, 2023 |
| FY2021 | Dec 31, 2019 | 1 | Mar 1, 2022 |
| FY2020 | Dec 31, 2018 | 1 | Mar 1, 2021 |
| FY2019 | Dec 31, 2017 | 1 | Mar 2, 2020 |
| FY2018 | Dec 31, 2016 | 1 | Mar 1, 2019 |
EPS (Diluted)
Net income divided by the fully diluted share count — including all potential shares from options, warrants, and convertible instruments. The more conservative and widely cited EPS figure.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 5 | Mar 10, 2026 |
| FY2025 | Dec 31, 2024 | 5 | Mar 10, 2026 |
| FY2025 | Dec 31, 2023 | 4 | Mar 10, 2026 |
| FY2024 | Dec 31, 2022 | 3 | Mar 11, 2025 |
| FY2023 | Dec 31, 2021 | 2 | Feb 27, 2024 |
| FY2022 | Dec 31, 2020 | 1 | Feb 28, 2023 |
| FY2021 | Dec 31, 2019 | 1 | Mar 1, 2022 |
| FY2020 | Dec 31, 2018 | 1 | Mar 1, 2021 |
| FY2019 | Dec 31, 2017 | 1 | Mar 2, 2020 |
| FY2018 | Dec 31, 2016 | 1 | Mar 1, 2019 |
Shares Outstanding
Total common shares issued and held by all shareholders, excluding treasury shares. Combined with market price gives market capitalization.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 32.07M | Mar 10, 2026 |
| FY2025 | Dec 31, 2024 | 32.11M | Mar 10, 2026 |
| FY2024 | Dec 31, 2023 | 32.00M | Mar 11, 2025 |
| FY2023 | Dec 31, 2022 | 31.97M | Feb 27, 2024 |
| FY2022 | Dec 31, 2021 | 31.83M | Feb 28, 2023 |
| FY2021 | Dec 31, 2020 | 31.61M | Mar 1, 2022 |
| FY2020 | Dec 31, 2019 | 31.51M | Mar 1, 2021 |
| FY2019 | Dec 31, 2018 | 31.38M | Mar 2, 2020 |
| FY2018 | Dec 31, 2017 | 31.24M | Mar 1, 2019 |
| FY2017 | Dec 31, 2016 | 31.14M | Mar 13, 2018 |
Dividends Paid
Cash dividends distributed to common shareholders during the period. Shown as a positive value despite being a cash outflow in the SEC filing.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $102.72M | Mar 10, 2026 |
| FY2025 | Dec 31, 2024 | $96.03M | Mar 10, 2026 |
| FY2025 | Dec 31, 2023 | $80.05M | Mar 10, 2026 |
| FY2024 | Dec 31, 2022 | $63.74M | Mar 11, 2025 |
| FY2023 | Dec 31, 2021 | $31.69M | Feb 27, 2024 |
| FY2022 | Dec 31, 2020 | $20.81M | Feb 28, 2023 |
| FY2021 | Dec 31, 2019 | $34.58M | Mar 1, 2022 |